Publications by authors named "Manoj Gowda S"

3 Publications

  • Page 1 of 1

Role of MRI in predicting response to neo-adjuvant systemic therapy (NAST) in breast cancer.

Breast Dis 2022 ;41(1):165-173

Department of Breast Surgery, University Hospitals of North Midlands, Stoke-on-Trent, United Kingdom.

Background And Objectives: MRI is generally performed to assess response to Neo-adjuvant systemic therapy (NAST) in breast cancer.

Objective: To assess role of MRI in determining the probability of having residual disease in patients undergoing NAST. We also evaluated synchronous cancers diagnosed following MRI.

Methods: This is a retrospective study which included all patients who had pre-and post-NAST MRI between June 2014 and December 2019. Data on demographics, tumour characteristics and pathology were collected and analysed. Pre- and post-MRI probability were calculated and depicted on nomograms.

Results: The study included 205 patients. Overall pre-MRI probability of having residual disease was 55% (OR:1.2). The post-MRI probability was 78% (95% CI 72-83%; OR:3.5) if MRI showed residual disease and 23% (95% CI 16-31%, OR:0.3) if imaging showed complete response. The absolute benefit was higher in TNBC and HR-HER2. Additional cancers were identified in 8.78% of patients.

Conclusion: MRI is beneficial in evaluating response to NAST specifically in TNBC and HR-HER2 cancers. Pre- and post-MRI probabilities of residual disease depicted on nomograms are a useful tool for clinicians. MRI can potentially impact the treatment decisions by identification of synchronous cancers.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.3233/BD-210023DOI Listing
March 2022

Breast Cancer Management Guidelines During COVID-19 Pandemic.

Indian J Surg 2020 Jul 2:1-8. Epub 2020 Jul 2.

Keele University, Newcastle-under-Lyme, Staffordshire UK.

The coronavirus disease (COVID-19) pandemic in 2020 has brought about complex challenges in healthcare delivery. With the new rules of lockdown and social distancing and with resources diverted to the management of COVID-19, there are difficulties in continuing usual cancer care. Patients are at risk of contracting COVID-19 with a high chance of patient to healthcare transmission and vice versa. Hospital visits, investigations and all modalities of treatment have potential complications that put patients at risk, some more than others. In this situation, there is a need to change our approach in the management of breast cancer to deliver it safely. We present modified guidelines based on the available consensus statements and evidence.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12262-020-02466-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329358PMC
July 2020

A prospective study of the Bedside Index for Severity in Acute Pancreatitis (BISAP) score in acute pancreatitis: an Indian perspective.

Pancreatology 2014 Sep-Oct;14(5):335-9. Epub 2014 Jul 22.

Department of General Surgery, SCB Medical College, Cuttack, Odisha, 753007, India.

Introduction: A simple and easily applicable system for stratifying patients with acute pancreatitis is lacking. The aim of our study was to evaluate the ability of BISAP score to predict mortality in acute pancreatitis patients from our institution and to predict which patients are at risk for development of organ failure, persistent organ failure and pancreatic necrosis.

Methods: All patients with acute pancreatitis were included in the study. BISAP score was calculated within 24 h of admission. A Contrast CT was used to differentiate interstitial from necrotizing pancreatitis within seven days of hospitalization whereas Marshall Scoring System was used to characterize organ failure.

Results: Among 246 patients M:F = 153:93, most common aetiology among men was alcoholism and among women was gallstone disease. 207 patients had no organ failure and remaining 39 developed organ failure. 17 patients had persistent organ failure, 16 of those with BISAP score ≥3. 13 patients in our study died, out of which 12 patients had BISAP score ≥3. We also found that a BISAP score of ≥3 had a sensitivity of 92%, specificity of 76%, a positive predictive value of 17%, and a negative predictive value of 99% for mortality.

Discussion: The BISAP score is a simple and accurate method for the early identification of patients at increased risk for in hospital mortality and morbidity.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pan.2014.07.007DOI Listing
June 2015
-->